On May 11, 2016, an application for authority to retain professionals was filed in the bankruptcy case of NephroGenex, Inc. and its affiliates.
The filing was assigned docket number 35 and is described on the court’s official docket as follows:
Application/Motion to Employ/Retain Cassel Salpeter & Co., LLC as Investment Banker to the Debtor, Nunc Pro Tunc to the Petition Date, and (II) Waiving Certain Reporting Requirements Pursuant to Local Rule 2016-2. Filed by NephroGenex, Inc.. Hearing scheduled for 6/2/2016 at 02:00 PM at US Bankruptcy Court, 824 Market St., 6th Fl., Courtroom #3, Wilmington, Delaware. Objections due by 5/25/2016. (Attachments: # (1) Notice of Motion # (2) Exhibit A – Proposed Order # (3) Exhibit B – Engagement Agreement # (4) Exhibit C – Cassel Declaration) (Hurst, David)
NephroGenex, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on April 30, 2016. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 16-11074. The bankruptcy case is currently assigned to United States Bankruptcy Judge Judge Not Yet Assigned. The law firm of Cole, Schotz, Meisel, Forman & Leonard, P.A. is acting as lead bankruptcy counsel to NephroGenex, Inc. in the bankruptcy case.